C.Q. Pharmaceutical Holding Co., Ltd. (SHE:000950)
China
· Delayed Price · Currency is CNY 5.07
-0.01 (-0.20%)
Jul 4, 2025, 2:45 PM CST
SHE:000950 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 305.27 | 282.99 | 624.63 | 952.28 | 1,005 | 884.34 | Upgrade
|
Depreciation & Amortization | 448.8 | 448.8 | 396.81 | 403.9 | 312.62 | 124.75 | Upgrade
|
Other Amortization | 93.72 | 93.72 | 48.52 | 33.17 | 37.51 | 26.58 | Upgrade
|
Loss (Gain) From Sale of Assets | -10.53 | -10.53 | -0.79 | -10.05 | -3.52 | -21.62 | Upgrade
|
Asset Writedown & Restructuring Costs | 40.21 | 40.21 | 20.49 | 27.93 | 10.67 | 14.76 | Upgrade
|
Loss (Gain) From Sale of Investments | -409.33 | -409.33 | -317.71 | -305.8 | -429.57 | -301.22 | Upgrade
|
Provision & Write-off of Bad Debts | 531.72 | 531.72 | 388.33 | 124.48 | 282.22 | 101.09 | Upgrade
|
Other Operating Activities | 2,263 | 1,299 | 1,505 | 1,336 | 1,053 | 788.23 | Upgrade
|
Change in Accounts Receivable | -1,663 | -1,663 | -5,316 | -3,878 | -3,989 | -2,343 | Upgrade
|
Change in Inventory | -1,432 | -1,432 | -752.22 | -1,824 | -185.46 | -51.37 | Upgrade
|
Change in Accounts Payable | 728.6 | 728.6 | 4,007 | 3,401 | 2,183 | 1,439 | Upgrade
|
Operating Cash Flow | 800.08 | -186.74 | 508.53 | 285.83 | 250.16 | 631.99 | Upgrade
|
Operating Cash Flow Growth | 77.44% | - | 77.92% | 14.26% | -60.42% | 212.23% | Upgrade
|
Capital Expenditures | -282.95 | -250.53 | -244.41 | -268.07 | -489.55 | -378.16 | Upgrade
|
Sale of Property, Plant & Equipment | 0.99 | 1.4 | 0.83 | 6.59 | 11.65 | 27.56 | Upgrade
|
Cash Acquisitions | -116.76 | -109.33 | -187.75 | -226.86 | -650.59 | -1,491 | Upgrade
|
Divestitures | 0.4 | - | -28.9 | 81.85 | 33.3 | - | Upgrade
|
Investment in Securities | 41.38 | 41.04 | 68.49 | 168.16 | -39.84 | -185.95 | Upgrade
|
Other Investing Activities | 64.86 | 85.54 | 24.94 | 47.09 | 165.52 | 41.04 | Upgrade
|
Investing Cash Flow | -242.66 | -182.46 | -358.38 | -191.24 | -969.51 | -1,957 | Upgrade
|
Long-Term Debt Issued | - | 24,230 | 25,555 | 24,481 | 28,019 | 22,651 | Upgrade
|
Long-Term Debt Repaid | - | -23,652 | -26,513 | -21,746 | -24,862 | -20,440 | Upgrade
|
Net Debt Issued (Repaid) | 733.94 | 578.14 | -958.02 | 2,735 | 3,157 | 2,211 | Upgrade
|
Issuance of Common Stock | - | - | - | - | 41.9 | - | Upgrade
|
Common Dividends Paid | -1,091 | -1,120 | -1,299 | -928.81 | -1,227 | -664.92 | Upgrade
|
Other Financing Activities | 665.16 | 590.28 | 2,510 | -626.11 | -429.17 | 81.35 | Upgrade
|
Financing Cash Flow | 307.74 | 48.33 | 252.49 | 1,180 | 1,542 | 1,627 | Upgrade
|
Foreign Exchange Rate Adjustments | - | - | - | - | -0.12 | -0.01 | Upgrade
|
Net Cash Flow | 865.17 | -320.87 | 402.64 | 1,274 | 822.74 | 301.83 | Upgrade
|
Free Cash Flow | 517.13 | -437.27 | 264.13 | 17.76 | -239.38 | 253.82 | Upgrade
|
Free Cash Flow Growth | 148.64% | - | 1386.93% | - | - | - | Upgrade
|
Free Cash Flow Margin | 0.63% | -0.54% | 0.34% | 0.03% | -0.38% | 0.56% | Upgrade
|
Free Cash Flow Per Share | 0.29 | -0.25 | 0.15 | 0.01 | -0.14 | 0.15 | Upgrade
|
Cash Income Tax Paid | 1,371 | 1,438 | 1,755 | 1,384 | 1,351 | 983.63 | Upgrade
|
Levered Free Cash Flow | 492.34 | -1,389 | 1,225 | -2,481 | -3,830 | -5,510 | Upgrade
|
Unlevered Free Cash Flow | 1,150 | -677.52 | 2,063 | -1,778 | -3,139 | -5,087 | Upgrade
|
Change in Net Working Capital | -122.39 | 1,740 | -639.03 | 3,308 | 4,360 | 5,962 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.